SCHEMBL13817839

SCHEMBL13817839

CO[C@H]1C[C@@H](C)C/C(C)=C/[C@@H](C)C(=O)C[C@H](O)[C@@H](C)[C@@H](/C(C)=C/[C@@H]2CC[C@@H](O)[C@H](OC)C2)OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@H]1[C@@H](OC)C[C@H]2C

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 18/20 0.86
FKBP4 Q02790 2/20 0.86
MEN1 O00255 1/20 0.86
LMNA P02545 1/20 0.86
MAPT P10636 1/20 0.86
KMT2A Q03164 1/20 0.86
THRB P10828 1/20 0.86
ABCB11 O95342 2/20 0.83
ADORA3 P0DMS8 2/20 0.83
MLNR O43193 1/20 0.83
NR1I2 O75469 1/20 0.83
CYP3A4 P08684 1/20 0.83
ADRA2A P08913 1/20 0.83
ADRB3 P13945 1/20 0.83
CYP3A5 P20815 1/20 0.83
TBXA2R P21731 1/20 0.83
CYP3A7 P24462 1/20 0.83
HTR2A P28223 1/20 0.83
HTR2B P41595 1/20 0.83
MTOR P42345 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13900961 1.00 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL7151109 1.00 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL6942031 1.00 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL13817750 1.00 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL6704927 1.00 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL29385547 1.00 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL14252227 0.96 FKBP1A (0.79) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL23220276 0.94 ABCB11 (0.87) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL13900965 0.94 ABCB11 (0.87) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL13817755 0.94 FKBP1A (0.77) FKBP1AFKBP4MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10259827-B2 BMP potentiators NOVARTIS AG (CH) 2019-04-16 US disclosed
US-20180127436-A1 BMP POTENTIATORS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2018-05-10 US disclosed
US-7553842-B2 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases ARRAY BIOPHARMA INC. (US) 2009-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10259827-B2 BMP potentiators BMP1, BMP2, BMP4 FKBP1A 1947/4885FKBP4 2752/4885MEN1 161/4885
US-20180127436-A1 BMP POTENTIATORS BMP1, BMP2, BMP4 FKBP1A 1947/4885FKBP4 2752/4885MEN1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.